AI-generated summary
The authors present a narrative overview of non-pharmacological treatments for depression and anxiety in Parkinson's disease, including cognitive-behavioral therapy, brain stimulation, electroconvulsive therapy, light therapy and exercise. They report meta-analytic evidence for benefit on depressive symptoms, with cognitive-behavioral therapy showing large effects on anxiety, while evidence for other anxiety treatments is limited. The treatments are described as safe, with no or mild side effects.
- Who or what was studied
- Individuals with Parkinson's disease experiencing depression or anxiety
- Limits stated in the abstract
- The abstract describes a narrative literature overview and states that evidence for non-pharmacological treatments of anxiety, apart from cognitive-behavioral therapy, is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Anxiety, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.